Cyclin Y interacts with Chk1 to activate RRM2/STAT3 signaling and promotes radioresistance in non-small cell lung cancer
International Journal of Biological Sciences · 2025
DOI: 10.7150/ijbs.106925 ↗At a glance
Journal article in International Journal of Biological Sciences, 2025. Written by Zhiwei Liu and 5 co-authors. Institution: Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China. Major MEDLINE topics: Carcinoma, Non-Small-Cell Lung, STAT3 Transcription Factor, Ribonucleoside Diphosphate Reductase, Lung Neoplasms. Cited 5 times so far (Crossref). The full text is freely available in PubMed Central.
Abstract (original language)
Radioresistance is one of the main reasons for the recurrence and metastasis of non-small cell lung cancer. Cyclin Y has been implicated in various cellular processes such as cell growth, proliferation, autophagy, and tumor progression. However, the function and regulatory mechanism of Cyclin Y in lung cancer radioresistance remain poorly understood. In this study, we find that Cyclin Y is overexpressed in non-small cell lung cancer and correlates with poor prognosis. Furthermore, knockdown of Cyclin Y results in inhibited cell growth and proliferation, increases DNA damage, impairs DNA damage repair, and enhances radiosensitivity in vitro and in vivo. Mechanistically, we uncover that Cyclin Y interacts with Chk1 and positively regulate both the mRNA and protein levels of RRM2, resulting in increased STAT3 phosphorylation. Rescue experiments confirm that the effects of Cyclin Y on lung cancer are mediated partially by RRM2. Collectively, we reveal for the first time that Cyclin Y promotes lung cancer radioresistance by binding to Chk1 to activate RRM2/STAT3 signaling, indicating that targeting Cyclin Y may be a promising strategy for enhancing the efficacy of radiotherapy in the treatment of non-small cell lung cancer.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
- Hubei Key Laboratory of Precision Radiation Oncology, Wuhan 430022, China.
- Institute of Radiation Oncology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
Cite
APA
Liu, Z., Xue, H., Wang, Z., Zhao, Y., Xu, S., & Dong, X. (2025). Cyclin Y interacts with Chk1 to activate RRM2/STAT3 signaling and promotes radioresistance in non-small cell lung cancer. International Journal of Biological Sciences. https://doi.org/10.7150/ijbs.106925
Vancouver
Liu Z, Xue H, Wang Z, Zhao Y, Xu S, Dong X. Cyclin Y interacts with Chk1 to activate RRM2/STAT3 signaling and promotes radioresistance in non-small cell lung cancer. International Journal of Biological Sciences. 2025. doi:10.7150/ijbs.106925
BibTeX
@article{Liu2025,
author = {Liu, Zhiwei and Xue, Huichan and Wang, Zhi and Zhao, Ye and Xu, Shuangbing and Dong, Xiaorong},
title = {Cyclin Y interacts with Chk1 to activate RRM2/STAT3 signaling and promotes radioresistance in non-small cell lung cancer},
journal = {International Journal of Biological Sciences},
year = {2025},
doi = {10.7150/ijbs.106925}
}
EUVIMED